Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cave

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Biochemical Pharmacology|April 8, 2022
Obesity I: Overview and molecular and biochemical mechanismsRobert H Lustig, David Collier, Christopher Kassotis, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 10, 2025
Perfluorooctane sulfonate (PFOS) exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding modelFrederick A Ekuban, Tyler C Gripshover, Paxton Ames, et al.
Bioinformatics (Oxford, England)|June 30, 2026
Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and MediatorsXincheng Li, Maiying Kong, Matthew Ryan Smith, et al.
The American Journal of Clinical Nutrition|May 25, 2023
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies WorkshopJerrold J Heindel, Jessica A Alvarez, Ella Atlas, et al.
Biochemical Pharmacology|April 8, 2022
Obesity II: Establishing causal links between chemical exposures and obesityJerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Biochemical Pharmacology|June 17, 2022
Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015]Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Biochemical Pharmacology|April 8, 2022
Obesity I: Overview and molecular and biochemical mechanismsRobert H Lustig, David Collier, Christopher Kassotis, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 10, 2025
Perfluorooctane sulfonate (PFOS) exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding modelFrederick A Ekuban, Tyler C Gripshover, Paxton Ames, et al.
Bioinformatics (Oxford, England)|June 30, 2026
Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and MediatorsXincheng Li, Maiying Kong, Matthew Ryan Smith, et al.
The American Journal of Clinical Nutrition|May 25, 2023
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies WorkshopJerrold J Heindel, Jessica A Alvarez, Ella Atlas, et al.
Biochemical Pharmacology|April 8, 2022
Obesity II: Establishing causal links between chemical exposures and obesityJerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Biochemical Pharmacology|June 17, 2022
Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015]Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Pageof 16